UF researchers are seeking to determine differences in pancreatic volume between new-onset Type 1 Diabetes (T1D) patients, antibody positive subjects at increased risk for T1D, and healthy controls. The study will also be used to determine if pancreatic volume correlates with indirect biochemical markers of endocrine and exocrine pancreatic function.
If pancreatic volume assessment could be utilized as a marker of beta cell function in high risk patients, non-invasive pancreatic imaging could become an important part of staging diabetes risk.
This study is seeking young individuals without T1D and antibody positive family members, as well as those with T1D.
Individuals must be between 8 and 25 years of age. Find more information here.